…. 2013;38(4):365–76.Clare DF, Alexander FC, Mike S. Accelerated infliximab infusions are safe and well tolerated in patients with inflamma…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 22 of 2459… 0.652), but not in those without DU. The protective effects of bosentan were confirmed in all sensitivity analyses targeting PAH detect…
…e (SHAQ), health-related quality of life (HRQoL) measured using 36-Item Short Form Survey (SF-36) and Patient-Reported Outcome Measurement Information Sy…
…and strength. Although ageing is the most likely risk factor of sarcopenia, sarcopenia is prevalent even in non-elderly people. Type 2 dia…
Interpretable machine learning model for predicting recurrence in patients with diabetic foot ulcers
…ding for training and updating clinical guidelines.Introduction Diabetic foot ulcer (DFU) and peripheral vascular disease are serious and common complica…
… a dose of 0.5-1x10e7 cells/animal once every week for 5 weeks. Dinutuximab was administered via IP injection at 15 ug/animal twice a week.…
…r exceeding (>50X higher) pharmacodynamic responses reported to vidutolimod, yet with minimal inflammatory cytokine secretion. RNA-seq show…
…ssessed in the first trimester. Adverse pregnancy outcomes were gestational diabetes, pre-eclampsia, emergency Caesarean section, still birth (after…
…unding factor. Regardless, positive FIT significantly increases CRC diagnosis. Consideration should be given to include FIT in USCI…
…peptide-1 receptor agonists (GLP-1RAs) are increasingly used in cardiometabolic disease for their anti-obesity and anti-diabetic effects, showing great…
….2% but not everyone at risk was tested. Some declined germline Lynch syndrome testing due to a lack of at-risk family members and delay getti…
… cell, urinary exosome, and cell-free urine) from biopsy-proven DKD, NDKD, T2DM without kidney disease and healthy subjects (n=40/g…